This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Veritone Enters Oversold Territory
by Zacks Equity Research
Veritone has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
4 Business Services Stocks Set to Top Q2 Earnings Estimates
by Zacks Equity Research
Business services sector earnings are expected to benefit from overall economic strength.
Non-cigarette to Drive Core-Mark's (CORE) Earnings in Q2
by Zacks Equity Research
Core-Mark's (CORE) second-quarter 2019 results to benefit from increase in sales of high margin alternative nicotine, food and candy products.
Earnings Preview: Veritone, Inc. (VERI) Q1 Earnings Expected to Decline
by Zacks Equity Research
Veritone, Inc. (VERI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veritone, Inc. (VERI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Veritone, Inc. (VERI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veritone (VERI) Catches Eye: Stock Jumps 9.8%
by Zacks Equity Research
Veritone (VERI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Implied Volatility Surging for Veritone (VERI) Stock Options
by Zacks Equity Research
Veritone (VERI) needs investors to pay close attention to the stock based on moves in the options market lately.
Veritone, Inc. (VERI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Veritone, Inc. (VERI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stericycle (SRCL) Q1 Earnings: Is Disappointment in Store?
by Zacks Equity Research
Lower organic revenue growth, unfavorable impact of divestures, non-cash goodwill impairment charges and expenses related to business transformation are likely to hurt Stericycle's (SRCL) Q1 results.
AI Provider Veritone (VERI) Plummets After Citron Research Tweet
by Madeleine Johnson
On Wednesday, shares of artificial intelligence technology company Veritone Inc. (VERI) are plummeting after Citron Research spelled out a brutal future for the company on Twitter (TWTR).
Why Veritone Trades Like A Roller-coaster
by Brian Bolan
Technicals, fundamentals, and tweets all seem to move this, but the real reason it moves up and down this much is something else.